Tuesday briefing: Palantir’s rise – and why so many oppose its role in the British state

In today’s newsletter: Its software is used from health services to militaries. But controversies and criticism of the $375bn company are leading some to ask if Palantir is too powerfulGood morning. The Peter Mandelson story keeps unfolding. Peter Walker explains here what is in the latest release of documents, and Henry Dyer takes a look at the key papers missing from the latest disclosures. But today we are covering another major story – Palantir.Few companies attract controversy more than Palantir. Since the pandemic, the US data analytics company has grown voraciously, using its AI-driven software to make sense of intractable datasets for customers around the world. For the NHS, it analyses patient records; for the US military, it’s focused on targets in Iran. Palantir’s products are